A Greater Power: US FDA May Become More Insistent On Timing Of Accelerated Approval Confirmatory Trials

Bolstered by new statutory authority and the Oncology Center of Excellence’s experience in pushing for early initiation of confirmatory trials, review divisions may take a tougher line with sponsors on the design and timing of studies to verify clinical benefit.